UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nonlinear mixed‐effects modeling of longitudinal count data: Bayesian inference about median counts based on the marginal zero‐inflated discrete Weibull distribution

Statistics in medicine, 2021-10, Vol.40 (23), p.5078-5095

2021

Volltextzugriff (PDF)

Bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquiline

American journal of respiratory and critical care medicine, 2015-04, Vol.191 (8), p.943-953

2015

Volltextzugriff (PDF)

Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial

The lancet respiratory medicine, 2019-12, Vol.7 (12), p.1048-1058

2019

Volltextzugriff (PDF)

Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis

Antimicrobial agents and chemotherapy, 2020-03, Vol.64 (4)

2020

Volltextzugriff (PDF)

Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies

The AAPS journal, 2024-04, Vol.26 (3), p.50, Article 50

2024

Volltextzugriff (PDF)

Correction: Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies

The AAPS journal, 2024-05, Vol.26 (3), p.58, Article 58

2024

Volltextzugriff (PDF)

Long‐term spatially‐replicated data show no physical cost to a benefactor species in a facilitative plant–plant interaction

Oikos, 2023-04, Vol.2023 (4), p.n/a

2023

Volltextzugriff (PDF)

Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials

BMC medicine, 2016-02, Vol.14 (19), p.19-19, Article 19

2016

Volltextzugriff (PDF)

Reply to Kim et al., "Optimal Dose or Optimal Exposure? Consideration for Linezolid in Tuberculosis Treatment"

Antimicrobial agents and chemotherapy, 2020-06, Vol.64 (7)

2020

Volltextzugriff (PDF)

A robust mixed‐effects parametric quantile regression model for continuous proportions: Quantifying the constraints to vitality in cushion plants

Statistica Neerlandica, 2023-11, Vol.77 (4), p.444-470

2023

Volltextzugriff (PDF)

Accuracy and precision of alternative estimators of ectoparasiticide efficacy

Veterinary parasitology, 2016-06, Vol.223, p.50-56

2016

Volltextzugriff (PDF)

Effect of uncertainty in total parasite infestation on accuracy and precision of estimates of ectoparasiticide efficacy

Veterinary parasitology, 2016-10, Vol.230, p.6-8

2016

Volltextzugriff (PDF)

Erratum to: Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials

BMC medicine, 2016-02, Vol.14 (35), p.36-36, Article 36

2016

Volltextzugriff (PDF)

Virulence and survival of native entomopathogenic nematodes for the management of white grubs in South Africa

Biological control, 2019-10, Vol.137, p.104043, Article 104043

2019

Volltextzugriff (PDF)

A robust method for the assessment of average bioequivalence in the presence of outliers and skewness

Pharmaceutical research, 2021-10, Vol.38 (10), p.1697-1709

2021

Volltextzugriff (PDF)

Robust fit of Bayesian mixed effects regression models with application to colony forming unit count in tuberculosis research

Statistics in medicine, 2018-02, Vol.37 (4), p.544-556

2018

Volltextzugriff (PDF)

A Bayesian Nonlinear Mixed-Effects Regression Model for the Characterization of Early Bactericidal Activity of Tuberculosis Drugs

Journal of biopharmaceutical statistics, 2015-11, Vol.25 (6), p.1247-1271

2015

Volltextzugriff (PDF)

A robust Bayesian mixed effects approach for zero inflated and highly skewed longitudinal count data emanating from the zero inflated discrete Weibull distribution

Statistics in medicine, 2020-04, Vol.39 (9), p.1275-1291

2020

Volltextzugriff (PDF)

Robust Bayesian nonlinear mixed‐effects modeling of time to positivity in tuberculosis trials

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2018-09, Vol.17 (5), p.615-628

2018

Volltextzugriff (PDF)

A generalized Bayesian nonlinear mixed‐effects regression model for zero‐inflated longitudinal count data in tuberculosis trials

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2019-07, Vol.18 (4), p.420-432

2019

Volltextzugriff (PDF)

Cone Normal Stepping

Burger, Divan Desmond

2018

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(21)
Dissertationen
(1)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(18)
Humans
(9)
Mathematics
(8)
Physical Sciences
(8)
Pharmacology & Pharmacy
(7)
Statistics & Probability
(7)
Tuberculosis
(7)
Bayesian
(6)
Antitubercular Agents - Therapeutic Use
(5)
Adult
(4)
Bayesian Analysis
(4)
Female
(4)
General & Internal Medicine
(4)
Male
(4)
Sputum - Microbiology
(4)
Antitubercular Agents
(3)
Bayes Theorem
(3)
Biochemistry
(3)
Biomedical And Life Sciences
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis

Nonlinear mixed‐effects modeling of longitudinal count data: Bayesian inference about median counts based on the marginal zero‐inflated discrete Weibull distribution

Bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquiline

Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial

Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis

Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies

Correction: Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies

Long‐term spatially‐replicated data show no physical cost to a benefactor species in a facilitative plant–plant interaction

Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials

Reply to Kim et al., "Optimal Dose or Optimal Exposure? Consideration for Linezolid in Tuberculosis Treatment"

A robust mixed‐effects parametric quantile regression model for continuous proportions: Quantifying the constraints to vitality in cushion plants

Accuracy and precision of alternative estimators of ectoparasiticide efficacy

Effect of uncertainty in total parasite infestation on accuracy and precision of estimates of ectoparasiticide efficacy

Erratum to: Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials

Virulence and survival of native entomopathogenic nematodes for the management of white grubs in South Africa

A robust method for the assessment of average bioequivalence in the presence of outliers and skewness

Robust fit of Bayesian mixed effects regression models with application to colony forming unit count in tuberculosis research

A Bayesian Nonlinear Mixed-Effects Regression Model for the Characterization of Early Bactericidal Activity of Tuberculosis Drugs

A robust Bayesian mixed effects approach for zero inflated and highly skewed longitudinal count data emanating from the zero inflated discrete Weibull distribution

Robust Bayesian nonlinear mixed‐effects modeling of time to positivity in tuberculosis trials

A generalized Bayesian nonlinear mixed‐effects regression model for zero‐inflated longitudinal count data in tuberculosis trials

Cone Normal Stepping

Suchergebnisse filtern